Pure Global
NCT06287177

Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Inclisiran in Italy

Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Inclisiran in Italy - CHOLINET (CHOLesterol Italian Inclisiran NETwork)
Federico II University·ClinicalTrials.gov·drugRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Hypercholesterolemia
Drug/Device/Intervention
Inclisiran
Study type
Observational
Intervention type
drug
Sponsor & location
Primary sponsor
Federico II University
Location
Napoli, Italy
Timeline & enrollment
Phase
N/A
Start date
Nov 01, 2022
End date
Nov 01, 2024
Enrollment
1000 participants
Primary outcome

Description of adherence to treatment with Inclisiran in a real-life Italian population,Description of persistence to treatment with Inclisiran in a real-life Italian population,Description of efficacy of treatment with Inclisiran in a real-life Italian population

Summary

Evaluation of adherence, persistence and efficacy of treatment with Inclisiran in a real-life
 Italian population

ICD-10 classifications
Pure hypercholesterolaemiaLipoprotein deficiencyHyperglycaemia, unspecifiedDisorders of lipoprotein metabolism and other lipidaemiasOther disorders of lipoprotein metabolism
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06287177
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06287177 through Pure Global AI's free database. This phase not specified trial is sponsored by Federico II University and is currently Recruiting. The study focuses on Hypercholesterolemia. Target enrollment is 1000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.